ESC Heart Failure

Papers
(The H4-Index of ESC Heart Failure is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Real-Time Pulmonary Artery Pressure Monitoring in Heart Failure Patients: An Updated Cost-Effectiveness Analysis151
Cardiovascular risk associated with polypharmacy in heart failure: a systematic review and meta-analysis97
Meta-Analysis Global Group in Chronic Heart Failure Score for the Prediction of Mortality in Valvular Heart Disease96
Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity79
Explainable Machine Learning and Online Calculators to Predict Heart Failure Mortality in Intensive Care Units72
Use of Sodium Glucose Co-Transporter 2 Inhibitors in Acute Heart Failure: A Practical Guidance72
Predicting Cardiovascular Events with Fluoropyrimidine Chemotherapy Using a Standard Cardiovascular Risk Calculator56
Global Differences in Acute Heart Failure Treatment: Analysis of the STRONG-HF Site Feasibility Questionnaire56
Long-Term Outcomes of Electrical Storm Patients Listed for Urgent Heart Transplantation but not Transplanted Acutely53
New insight: Particle Flow Rate from the Airways as an Indicator of Cardiac Failure in the Intensive Care Unit52
Calcium Channel Blockers and Clinical Outcomes in Patients with Continuous-Flow Left Ventricular Assist Devices51
Editors’ Highlight Picks from 2023 in ESC Heart Failure50
Impact of Age on Characteristics, Performance Measures and Outcomes of Inpatients for Heart Failure in Beijing, China49
Issue Information49
Reductions in Renin-Angiotensin System Inhibitors Following Hospitalization for Heart Failure44
Blood Perfusion Status is Important in the Prognosis of Ventricular Aneurysm Complicated by Ventricular Septal Rupture44
Analysis of the Serum Levels of RIP3 and Drp1 in Patients with Heart Failure44
Cardiac Involvement in Patients Recovering from Delta Variant of COVID-19: A Prospective Multi-Parametric MRI Study43
Meta-Analysis of Cardiac Magnetic Resonance in Prognosticating Left Ventricular Function in Peripartum Cardiomyopathy43
Integrated Care for Older Multimorbid Heart Failure Patients: Protocol for the ESCAPE Randomized Trial and Cohort Study43
Oral Milrinone for Management of Refractory Right Ventricular Failure in Patients with Left Ventricular Assist Devices43
Effect of SGLT2 inhibitors on hemoglobin and hematocrit levels in Heart failure: a systematic review and meta-analysis43
Prognostic Value of Left Atrial Strain in Acute and Chronic Heart Failure: A Meta-Analysis42
Transcatheter Aortic Valve Replacement in Aortic Stenosis and Cardiac Amyloidosis: A Systematic Review and Meta-Analysis42
Biomarker Profiles in Heart Failure with Preserved vs. Reduced Ejection Fraction: Results from the DIAST-CHF Study42
Heart Failure and Trimethylamine N-Oxide: Time to Transform a ‘Gut Feeling’ in a Fact?40
Fibroblast Growth Factor 23 Independently Predicts Adverse Outcomes After an Acute Coronary Syndrome40
38
Arterio-venous gradient of active interleukin-18 is associated with diastolic dysfunction: a cross-sectional study37
37
Effect of Beta-Blockade on Mortality in Patients with Cardiac Amyloidosis: A Systematic Review and Meta-Analysis36
Sex Differences in the Impact of Frailty on Patients with Heart Failure: A Retrospective Cohort Study36
Risk Classification for Long-Term Mortality Among Patients with Acute Heart Failure: China PEACE 4YMortality35
Atrial Fibrillation Ablation in Patients with Arrhythmia-Induced Cardiomyopathy: A Prospective Multicentre Study35
Percutaneous Endocardial Alginate–Hydrogel Injection in the Treatment of Heart Failure: First-in-Human Study35
0.22581815719604